10 Stocks Analysts Are Upgrading Today

Page 9 of 9

1. Argenx SE – ADR (NASDAQ:ARGX)

Stock Upgrade: Neutral to Outperform

Stock Price Target: $680

Stock Upside Potential as of May 13: 25.75%

Argenx SE – ADR (NASDAQ:ARGX) is a global immunology company that develops and commercializes novel antibody-based medicines for treating severe autoimmune diseases and cancer. It offers VYGART and VYGART HYTRULO to treat generalized myasthenia gravis (gMG), immune thrombocytopenia (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP). Robert W Baird upgraded the stock to an ‘Outperform’ from a ‘Neutral’ on expectations that its lead product, Vygart, is poised for long-term growth driven by volume.

The upgrade also comes on Argenx SE – ADR (NASDAQ:ARGX), delivering impressive first-quarter 2025 results. The company’s total product sales for VYGART and VYGART SC nearly doubled to $790 million compared to $398 million delivered the same quarter last year. Likewise, Argenx bounced to profitability with a profit of $169 million compared to a loss of $62 million for the same quarter the previous year.

While Vygart has been the catalyst behind the underlying growth, Argenx SE – ADR (NASDAQ:ARGX) is already advancing 10 phase 2 and 10 Phase 3 trials across efgartigimod, empasiprubart, and ARGX-11. It is part of an effort to expand into new therapeutic areas to unlock new growth opportunities. Robert W Baird expects a strong balance sheet to support long-term growth.

While we acknowledge the potential of Argenx SE – ADR (NASDAQ:ARGX) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than ARGX but that trades at less than 5 times its earnings check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 9 of 9